Total Funding
80
59
Total FundingDebt Financing raised
Growth Score
9 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
73524
Affibody is a Swedish biotech company focused on developing products for therapy, diagnostic imaging, and other applications.
- Peter Zerhouni: Chief Financial Officer and Chief Business OfficerPast Role: InDex Pharmaceuticals, Chief Executive Officer
About the Company
Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a large
number of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.
